Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040

被引：0
|
作者：
Eric Southam
Jackie Cilia
Jane E. Gartlon
Marie L. Woolley
Laurent P. Lacroix
Carol A. Jennings
Jane E. Cluderay
Charlie Reavill
Claire Rourke
David M. Wilson
Lee A. Dawson
Andrew D. Medhurst
Declan N. C. Jones
机构：
[1] GlaxoSmithKline,
来源：
Psychopharmacology | 2009年 / 201卷
关键词：
Antipsychotic; Autoradiography; c-; Cognition; Dopamine; Haloperidol; Histamine; Microdialysis; Prepulse inhibition; Schizophrenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：483 / 494
页数：11
相关论文
共 50 条
  • [1] Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040
    Southam, Eric
    Cilia, Jackie
    Gartlon, Jane E.
    Woolley, Marie L.
    Lacroix, Laurent P.
    Jennings, Carol A.
    Cluderay, Jane E.
    Reavill, Charlie
    Rourke, Claire
    Wilson, David M.
    Dawson, Lee A.
    Medhurst, Andrew D.
    Jones, Declan N. C.
    PSYCHOPHARMACOLOGY, 2009, 201 (04) : 483 - 494
  • [2] Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats
    Medhurst, Andrew D.
    Briggs, Michael A.
    Bruton, Gordon
    Calver, Andrew R.
    Chessell, Iain
    Crook, Barry
    Davis, John B.
    Davis, Robert P.
    Foley, Andrew G.
    Heslop, Teresa
    Hirst, Warren D.
    Medhurst, Stephen J.
    Ociepka, Sandrine
    Ray, Alison
    Regan, Ciaran M.
    Sargent, Becky
    Schogger, Joanne
    Stean, Tania O.
    Trail, Brenda K.
    Upton, Neil
    White, Trevor
    Orlek, Barry
    Wilson, David M.
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (08) : 1182 - 1194
  • [3] Preclinical pharmacology of the novel intranasal dual histamine H1 and H3 receptor antagonist GSK1004723
    Clark, K.
    Russell, L.
    Hall, D.
    Luttmann, M.
    Ford, A.
    Saunders, K.
    Changani, K.
    Hodgson, S.
    Connor, H.
    Browning, C.
    ALLERGY, 2009, 64 : 129 - 129
  • [4] Preclinical pharmacology of the novel oral dual histamine H1 and H3 receptor antagonist GSK835726
    Ford, A.
    Browning, C.
    Russell, L.
    Saunders, K.
    Hall, D.
    Morrison, V
    Changani, K.
    Hodgson, S.
    Connor, H.
    Clark, K.
    ALLERGY, 2009, 64 : 69 - 69
  • [5] GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models
    Medhurst, Andrew D.
    Atkins, Alan R.
    Beresford, Isabel J.
    Brackenborough, Kim
    Briggs, Michael A.
    Calver, Andrew R.
    Cilia, Jackie
    Cluderay, Jane E.
    Crook, Barry
    Davis, John B.
    Davis, Rebecca K.
    Davis, Robert P.
    Dawson, Lee A.
    Foley, Andrew G.
    Gartlon, Jane
    Gonzalez, M. Isabel
    Heslop, Teresa
    Hirst, Warren D.
    Jennings, Carol
    Jones, Declan N. C.
    Lacroix, Laurent P.
    Martyn, Abbe
    Ociepka, Sandrine
    Ray, Alison
    Regan, Ciaran M.
    Roberts, Jennifer C.
    Schogger, Joanne
    Southam, Eric
    Stean, Tania O.
    Trail, Brenda K.
    Upton, Neil
    Wadsworth, Graham
    Wald, Jeffrey A.
    White, Trevor
    Witherington, Jason
    Woolley, Marie L.
    Worby, Angela
    Wilson, David M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (03): : 1032 - 1045
  • [6] Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics
    von Coburg, Y.
    Kottke, T.
    Weizel, L.
    Ligneau, X.
    Stark, H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) : 538 - 542
  • [7] Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with Modafinil
    Uguen, M.
    Perrin, D.
    Belliard, S.
    Ligneau, X.
    Beardsley, P. M.
    Lecomte, J. M.
    Schwartz, J. C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (03) : 632 - 644
  • [8] A scalable synthesis of a histamine H3 receptor antagonist
    Mani, NS
    Jablonowski, JA
    Jones, TK
    JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (23): : 8115 - 8117
  • [9] A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
    Jarskog, L. Fredrik
    Lowy, Martin T.
    Grove, Richard A.
    Keefe, Richard S. E.
    Horrigan, Joseph P.
    Ball, M. Patricia
    Breier, Alan
    Buchanan, Robert W.
    Carter, Cameron S.
    Csernansky, John G.
    Goff, Donald C.
    Green, Michael F.
    Kantrowitz, Joshua T.
    Keshavan, Matcheri S.
    Laurelle, Marc
    Lieberman, Jeffrey A.
    Marder, Stephen R.
    Maruff, Paul
    McMahon, Robert P.
    Seidman, Larry J.
    Peykamian, Margaret A.
    SCHIZOPHRENIA RESEARCH, 2015, 164 (1-3) : 136 - 142
  • [10] The Histamine H4 Receptor Participates in the Neuropathic Pain-Relieving Activity of the Histamine H3 Receptor Antagonist GSK189254
    Borgonetti, Vittoria
    Galeotti, Nicoletta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
12345